Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

545.00
+3.380.62%
Pre-market: 546.171.17+0.21%06:19 EDT
Volume:1.01M
Turnover:550.71M
Market Cap:23.38B
PE:19.50
High:558.30
Open:542.41
Low:541.90
Close:541.62
52wk High:609.35
52wk Low:409.07
Shares:42.89M
Float Shares:39.35M
Volume Ratio:0.61
T/O Rate:2.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.65
PE(LYR):19.56

Loading ...

United Therapeutics CEO Martine Rothblatt disposes of shares worth $5.1 million

Reuters
·
Jun 04

United Therapeutics CFO James Edgemond disposes of common shares worth $4.87 million

Reuters
·
Jun 03

United Therapeutics Chairperson and CEO Martine Rothblatt disposes of USD 4.75 million in common shares

Reuters
·
Jun 02

United Therapeutics CFO James Edgemond disposes of 10,000 common shares worth $5.66 million

Reuters
·
May 30

United Therapeutics Chairperson, CEO Martine Rothblatt disposes of USD 4.63 million in common shares

Reuters
·
May 30

United Therapeutics CEO Chairperson Martine Rothblatt disposes of USD 5.02 million in common shares

Reuters
·
May 29

PHINDER Trial Update: How Earlier Pulmonary Hypertension Screening Could Shape United Therapeutics’ Market

TIPRANKS
·
May 29

United Therapeutics CFO James Edgemond sells USD 4.17 million in common shares

Reuters
·
May 28

United Therapeutics Advances High-Risk, High-Reward Xenokidney Trial for ESRD

TIPRANKS
·
May 28

United Therapeutics CFO James Edgemond presents at Jefferies Global Healthcare Conference

Reuters
·
May 27

United Therapeutics CEO Martine Rothblatt sells common shares worth $5.37 million

Reuters
·
May 27

Assessing United Therapeutics (UTHR) Valuation After Strong Recent Shareholder Returns

Simply Wall St.
·
May 26

United Therapeutics CFO James Edgemond disposes of shares worth $5.64 million

Reuters
·
May 23

United Therapeutics CEO Martine Rothblatt sells USD 5.36 million in common stock

Reuters
·
May 23

United Therapeutics CEO Martine Rothblatt disposes of USD 4.55 million in shares

Reuters
·
May 22

United Therapeutics EVP, General Counsel Paul Mahon disposes 8,300 shares for $4.67 million

Reuters
·
May 22

United Therapeutics CEO Martine Rothblatt disposes 9,500 shares for $5.39 million

Reuters
·
May 21

J.P. Morgan Keeps Their Buy Rating on United Therapeutics (UTHR)

TIPRANKS
·
May 20

United Therapeutics Corp : JP Morgan Resumes Coverage With Overweight Rating; Price Target $685

THOMSON REUTERS
·
May 20

United Therapeutics CFO James Edgemond disposes of USD 5.64 million common shares

Reuters
·
May 20